Side-by-side comparison
Anamorelin vs LL-37 Truncated Variants (KR-12 / KS-30)
Oral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz. versus Shorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.
Anamorelin
PerformanceOral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz.
Top benefits
- ✓Increases lean body mass
- ✓Improves appetite
- ✓Oral bioavailability
LL-37 Truncated Variants (KR-12 / KS-30)
RecoveryShorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.
Top benefits
- ✓Antimicrobial activity preserved
- ✓Lower hemolysis vs full LL-37
- ✓Wound healing research
| Attribute | Anamorelin | LL-37 Truncated Variants (KR-12 / KS-30) |
|---|---|---|
| Category | Performance | Recovery |
| Type | small-molecule | linear |
| Chain length | 1 aa | 12 aa |
| Formula | C31H42N6O3 | KR-12 fragment of LL-37 |
| Common dose | 100 mg | Not established |
| Frequency | Daily, oral | N/A |
| Top benefit | Increases lean body mass | Antimicrobial activity preserved |
| Top side-effect | Hyperglycemia | Localized irritation (topical) |
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.